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ABSTRACT
Non-surgical instrumentation associated with 
povidone-iodine in the treatment of interproximal 
furcation involvements
Érica Del Peloso RIBEIRO1, Sandro BITTENCOURT1	
	
2
		
2,
		!"#2$	%&&	

2
1- DDS, MSc, PHD, Bahiana School of Medicine and Public Health, Salvador, BA, Brazil.
2- DDS, MSc, PHD, Department of Prosthodontics and Periodontics, Division of Periodontics, Piracicaba Dental School, University of Campinas, Piracicaba, 
SP, Brazil.
Corresponding address: Márcio Zaffalon Casati - Avenida Limeira, 901 - Areião - 13414-903 - Piracicaba-SP - Phone: 19-2106-5301 - Fax: 19-2106-5301
e-mail: casati@fop.unicamp.br
#'()*++-//03	(4	)	6-/+/3
7()8+;-/+/
Objective: The aim of this controlled clinical trial was to evaluate the effect of topically applied povidone-iodine (PVP-I) used as an adjunct to non-surgical treatment of 
interproximal class II furcation involvements. Material and Methods: Thirty-two patients 
presenting at least one interproximal class II furcation involvement that bled on probing 
with probing pocket depth (PPD) 5 mm were recruited. Patients were randomly chosen 
to receive either subgingival instrumentation with an ultrasonic device using PVP-I (10%) 
as the cooling liquid (test group) or identical treatment using distilled water as the cooling 
liquid (control group). The following clinical outcomes were evaluated: visible plaque 
index, bleeding on probing (BOP), position of the gingival margin, relative attachment 
level (RAL), PPD and relative horizontal attachment level (RHAL). BAPNA (N-benzoyl-L-
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All parameters were evaluated at baseline and 1, 3 and 6 months after non-surgical 
subgingival instrumentation. Results: Six months after treatment, both groups had similar 
means of PPD reduction, RAL and RHAL gain (p>0.05). These variables were, respectively, 
2.20±1.10 mm, 1.27±1.02 mm and 1.33±0.85 mm in the control group and 2.67±1.21 
mm, 1.50±1.09 mm and 1.56±0.93 mm in the test group. No difference was observed 
between groups at none of the posttreatment periods, regarding the number of sites 
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test group had lower BAPNA values than control group. Conclusion: The use of PVP-I as 
an adjunct in the non-surgical treatment of interproximal class II furcation involvements 
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INTRODUCTION
Furcation involvements represent a great 
challenge to the success of periodontal therapy12. 
The reduced rate of success experienced in the 
treatment of furcation involvements seems to 
result from the incomplete removal of subgingival 
plaque and calculus in the interadicular area owing 
to the peculiar anatomy of the furcation space24,25. 
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control by the patient3.
Regarding the therapeutic approach, although 
furcation involvement treated with a conservative 
approach does not yield the same satisfactory 
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it has been shown that teeth with furcation 
involvement have a remarkable survival rate 
following conservative treatment21<
demonstrate that the conservative approach for 
furcation involvement can be performed with the 
expectation of a high long-term survival rate for 
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the patients demonstrating a satisfactory plaque 
control3.
Del Peloso Ribeiro, et al.7 (2006) showed in a 
randomized controlled clinical trial that non-surgical 
therapy can effectively treat buccal and lingual class 
II furcation involvements. However, Del Peloso 
Ribeiro, et al.8 (2007) also showed that buccal and 
lingual class II furcation involvements respond 
better to non-surgical therapy than interproximal 
class II furcation involvements.
In an attempt to improve the biological response 
of interproximal furcation involvement to non-
surgical periodontal therapy chemotherapeutic 
agents could be used. Povidone-iodine (PVP-I) is 
one of the most potent and widely used broad-
spectrum antiseptics available. It has a very 
rapidly bactericidal effect, being effective against 
periodontal pathogens in vitro in as little as 15 s 
of contact and in vivo within 5 min of contact4,11. 
PVP-I also fails to allow the development of bacterial 
resistance; has low systemic toxicity and low 
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2,15. In addition, allergic sensitization 
to PVP-I is rare28.
PVP-I has been used as an adjunct in the 
treatment of chronic periodontitis with promising 
results27. Rosling, et al.26 (2001) showed that PVP-I, 
used as the cooling liquid of an ultrasonic device, 
in conjunction with subgingival root debridement 
improved the outcome of non-surgical therapy 
in non-molar teeth. Hoang, et al.13 (2003) also 
demonstrated in non-molar teeth that the addition 
of subgingival PVP-I irrigation to conventional 
mechanical therapy caused a greater reduction in 
total pathogen counts.
The aim of the present study was to evaluate 
the effect of PVP-I, used as the cooling liquid of an 
ultrasonic device in the non-surgical treatment of 
interproximal class II furcation involvements.
MATERIAL AND METHODS
Study population
Thirty-two subjects were recruited from 
those referred for treatment to the Department 
of Periodontology of Piracicaba Dental School, 
State University of Campinas, Brazil. Subjects 
were enrolled from October 2005 to June 2006. 
All patients were individually informed about the 
nature of the proposed treatment and informed 
consent forms were signed. The study protocol was 
approved by the local Research Ethics Committee.
Power analysis indicated that 13 subjects would 
have 88% power to detect a 1-mm difference in 
clinical attachment level between the two groups. 
Subjects who were invited to participate met the 
following inclusion criteria: 1) diagnosis of severe 
chronic periodontitis by the presence of periodontal 
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bleeding on probing and radiographic bone loss9; 
2) at least one molar with class II interproximal 
furcation involvement10 that bled on probing, with 
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were: 1) furcation involvement in molars with 
periapical disease; 2) medical disorders that could 
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and root planing in the preceding 6 months; 4) 
consumption of drugs known to affect periodontal 
status within the past 6 months; 5) pregnancy; 
6) allergy to iodine; 7) thyroid dysfunction and 8) 
smoking habits.
Study design
This was a randomized parallel arm clinical trial 
with six months of duration. Patients initially received 
detailed information on the etiology of periodontal 
disease and instructions in proper self-performed 
plaque control measures, interdental cleaning 
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In the initial sessions, patients also had plaque 
retentive factors (caries, excess of restorations 
and supragingival calculus) removed. The baseline 
measurements were performed 21 days after this 
initial phase.
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bled on probing were treated with scaling and 
root planing (basic therapy). The non-surgical 
therapy on molars with furcation involvement was 
performed under local anesthesia by the use of an 
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(33R and 33L; Amdent, Stockholm, Sweden). The 
instrumentation of furcation involvements in the 
test group was combined with the administration 
of 10% PVP-I. In this group, the traditional cooling 
liquid of the ultrasonic device was replaced by PVP-I 
for the treatment of the interproximal furcation. 
Thus, not all the pathological sites of the test group 
received PVP-I. The furcation involvements of the 
control group received an identical treatment, but 
distilled water was used as the cooling liquid. The 
randomization was done by coin toss right after the 
patient was included in the study. The allocation 
concealment was secured by having a person not 
involved in the study performing the randomization. 
This person was different from the one responsible 
for the treatment (S. B.) and different from the 
examiner (E. D. P. R.). The person responsible for 
the treatment was a specialist in periodontics. The 
randomization code was not broken until all data 
had been collected. Thus, the treatment group 
was not revealed to the clinical examiner or to the 
statistician.
Only one cl inician was responsible for 
administering the treatment throughout the course 
of the study. This clinician was different from 
the calibrated examiner performing the clinical 
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measurements. The furcation involvements were 
instrumented until a smooth, hard surface was 
achieved.
After the active treatment, all subjects were 
included in a maintenance program composed 
of professional supragingival plaque control and 
reinforcement of oral hygiene instructions every 
15 days for the first month and every month 
until the sixth month. At the 3-month recall visit, 
sites that exhibited probing pocket depth 5 mm 
and bled on probing received subgingival therapy 
identical to that provided during the phase of basic 
therapy. The maintenance program also included 
an update of the medical and dental histories, 
extraoral and intraoral soft tissue examination, 
dental examination and periodontal evaluation.
Clinical measurements
The following clinical parameters were taken at 
baseline and at 1, 3 and 6 months after therapy. 
Visible plaque index (VPI)1 evaluated supragingival 
plaque accumulation dichotomously at six sites on 
all teeth in the mouth. Bleeding on probing (BOP)18 
was also measured dichotomously at six sites per 
tooth. Thus, VPI and BOP were calculated as full 
mouth percentage of presence of plaque and BOP.
An individual stent was fabricated of clear self-
curing resin, with a vertical groove at the place 
where the furcation involvement could be probed 
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location of periodontal probes at the furcation sites. 
The position of the gingival margin (PGM) was 
measured from the stent to the gingival margin and 
the relative attachment level (RAL) from the stent to 
the bottom of the periodontal pocket. The probing 
pocket depth (PPD) was calculated based on RAL 
and PMG. The relative horizontal attachment level 
(RHAL) was measured, using a curved periodontal 
probe (Neumar, São Paulo, SP, Brazil) with grooves 
at 1 mm intervals29 from the stent to the deepest 
horizontal point of the periodontal pocket. The 
clinical parameters VPI, BOP, PGM, RAL and PPD 
were measured using a standardized periodontal 
probe with 1 mm markings (PCPUNC 15®; Hu-
Friedy, Chicago, IL, USA).
Examiner Calibration
The investigator charged with cl inical 
assessments was calibrated for intraexaminer 
repeatability prior to the start of the trial. Three 
patients with chronic periodontitis were enrolled for 
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of intraexaminer reproducibility were 0.81, 0.88 and 
0.89 for mean PPD, RAL and RHAL, respectively.
Biochemical evaluation – BAPNA assay
The biochemical evaluation was done with 
the BAPNA test that permits the detection of 
microorganisms possessing trypsin-like enzymes 
such as Tannerella forsythensis, Treponema 
denticola and Porphyromonas gingivalis. Subgingival 
dental plaque was collected from furcation 
involvements with sterile Gracey curettes. Before 
the collection, the area was dried, isolated and had 
the supragingival plaque removed.
The plaque collected was placed in preweighed 
coded microcentrifuge tubes. To the tubes was 
added 1 mL of a solution containing the enzyme 
substrate N-benzoyl-L-arginine-p-nitroanilide 
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concentration of 1.0 nmol/L in the assay buffer 
(0.05 nmol/L Tris-HCl, 5 mM CaCl2, pH 7.5) that 
had 5% DMSO. This suspension was vortexed and 
then placed in an ultrasound bath on ice for 10 min 
with 2-s cycles and 2-s intervals at 17 W using a 
100 W ultrasonic processor. After 17 h of incubation 
at 37°C, the reaction was stopped with ice and by 
the addition of 100 L of glacial acetic acid. The 
absorbance was read at 405 nm. The results were 
given in nanomoles of product per minute per 
milligram of dental plaque wet weight20.
Statistical analysis
Repeated measures analysis of variance (ANOVA) 
was used to detect intra and intergroup differences 
in clinical parameters (VPI, BOP, PPD, RAL and 
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analysis of the difference was determined using the 
method of Tukey. The proportion of sites presenting 
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on probing at the furcation sites and number of 
lesions retreated at 3 and 6 months were compared 
between groups with chi-square analysis or Fischer’s 
exact test. The Friedman test was used to detect 
intragroup differences in biochemical parameter 
among all periods and the Mann-Whitney test to 
detect intergroup differences in this parameter at 
each time interval. All evaluations used the subject 
as the unit of measurement; averages were used if 
more than one site per subject existed. Individual 
furcation involvements were compared regarding 
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(alpha) was set at 0.05. RAL was considered as the 
primary outcome variable. All other parameters 
were considered secondary outcomes.
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RESULTS
Four patients did not show up for all the 
appointments, for reasons not related to the study; 
and thus, a total of 28 patients completed the study: 
15 of the control group and 13 of the test group. A 
total of 37 furcation involvements were evaluated: 
18 in the control group and 19 in the test group. The 
baseline data indicated that control and test groups 
were similar according to age, gender, clinical and 
biochemical parameters (Table 1).
Visible plaque index (VPI) and bleeding on 
probing (BOP)
VPI and BOP were reduced during the study 
in both groups, but no statistically significant 
difference was found between them (Table 2). 
BOP were measured for the whole mouth and also 
exclusively at the furcation involvements. In this 
case, no difference was observed between groups 
(Figure 1).
CARACTERISTIC CONTROL GROUP TEST GROUP
Age (range/ mean) 26-57/ 42.96 years 27-59/ 43.74 years
% Males 47.37% 46.15%
VPI (%)† 45.30 (±13.08) 43.96 (±16.02)
BOP (%) 34.60 (±11.05) 31.83 (±13.91)
PGM (mm) 2.35 (±0.68) 2.31 (±1.03)
PPD (mm) 6.98 (±1.53) 7.00 (±1.00)
RAL (mm) 9.33 (±1.64) 9.31 (±1.07)
RHAL (mm) 10.22 (±3.07) 10.97 (±1.72)
BAPNA (nmol/mg x min) 37.45 (±26.18) 45.97 (±22.22)
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(analysis by non-paired t test for age, by repeated measures ANOVA for clinical parameters and by Mann-Whitney test for 
biochemical parameter)   
† Note: Values of VPI and BOP refer to means of the whole mouth while values of PPD, CAL, RHAL and BAPNA refer to 
means of the furcation sites
VPI= visible plaque index; BOP= bleeding on probing; PGM= position of the gengival margin; PPD= probing pocket depth; 
RAL= relative attachment margin; RHAL= relative horizontal attachment level; BAPNA= N-benzoyl-L-arginine-p-nitroanilide
Table 1- Baseline means (± standard deviation) of age, gender, clinical and biochemical parameters*
#W
 CONTROL GROUP TEST GROUP
VPI
baseline 45.29±13.08 43.95±16.02
1 month 39.74±16.39 46.21±13.19
3 months 35.24±13.98** 32.52±10.34**
6 months 34.57±12.09** 30.51±13.96**
BOP
baseline 34.60±11.04 31.83±13.91
1 month 25.01±9.44*** 21.03±11.08***
3 months 21.47±10.13*** 19.23±8.47***
6 months 19.98±6.07*** 18.37±8.07***
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Table 2- Mean ± SD of visible plaque index (VPI) and bleeding on probing (BOP) values (%) at different time intervals for 
control and test groups*
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Clinical parameters – PGM, PPD, RAL and 
RHAL
Both groups showed, without significant 
difference between them, an increase in PGM, a 
reduction in PPD and a gain in RAL and RHAL (Table 
3). At 6 months, the mean decrease in PPD was 
2.20±1.10 mm in control group and 2.67±1.21 mm 
in test group. The mean gain in RAL and RHAL was 
1.27±1.02 mm and 1.33±0.85 mm in the control 
group and 1.50±1.09 mm and 1.56±0.93 mm in the 
test group, respectively. The results of PMG, PPD, 
RAL and RHAL refer strictly to the furcation sites.
#W
 CONTROL GROUP TEST GROUP
PGM
Baseline 2.40±1.06 2.00±0.97
1 month 3.00±1.11* 2.89 ±1.13*
3 months 3.13±0.94* 3.22±1.00*
6 months 3.33±0.99* 3.17±1.20*
PPD
Baseline 7.10±1.71 7.11±1.67
1 month 5.13±1.2* 5.05±1.16*
3 months 5.00±1.26* 4.83±1.29*
6 months 4.90±0.96* 4.44±1.19*
RAL
Baseline 9.50±2.05 9.11±1.81
1 month 8.13±1.57* 7.94±1.62*
3 months 8.13±1.63* 8.05±1.39*
6 months 8.23±1.30* 7.61±1.46*
RHAL
Baseline 11.20±2.34 10.61±2.20
1 month 10.00±1.89* 10.17±2.55*
3 months 9.73±1.64* 9.72±2.05*
6 months 8.87±1.65* 9.05±1.70*
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Table 3- Mean ± standard deviation of position of the gengival margin (PGM), probing pocket depth (PPD), relative attachment 
margin (RAL) and relative horizontal attachment level (RHAL) (mm) at different time intervals for control and test groups
Figure 1- Bleeding on probing (BOP) of furcation 
involvements at different time intervals for control and 
test groups Figure 2- Percentage of furcation involvements with 
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intervals for control and test groups.
* Difference (p<0.05) between groups by chi-square test.
Figure 3- Percentage of furcation involvements that 
needed re-treatment at different time intervals for control 
and test groups
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There was no difference between groups 
regarding the proportions of furcation presenting 
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the control group had 36.67% of sites showing a 
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3 months, these values were 30.00% and 26.31% 
and at 6 months, 33.33% and 42.10%, respectively.
Difference between groups was found regarding 
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after treatment (Figure 2). All furcations presented 
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therapy, 70.00% of the furcation involvements still 
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had this PPD in the test group.  At 3 months, the 
values were 66.67% and 52.63%, respectively. At 
6 months, 70.00% of the evaluated sites had PPD 
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The percentage of furcation sites that needed 
retreatment at 3 months was 43.33% in the control 
group and 36.84% in the test group. At 6 months, 
the values were 33.33% and 15.79%, respectively. 
These differences were not statistically different 
(Figure 3).
Biochemical parameter – BAPNA test
Table 4 presents the results of BAPNA at different 
time intervals. Both groups, at one and three 
months after treatment, showed a statistically 
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between groups. At 6 months, only the test group 
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between groups on BAPNA values at 6 months.
DISCUSSION
The conservative approach of furcation 
involvements is effective in the treatment of buccal 
and lingual class II furcation lesions in patients 
demonstrating a satisfactory plaque control7. 
However, interproximal furcation involvements 
do not show the same biological response to 
non-surgical treatment probably because of 
the irregular anatomy of the area that impairs 
professional plaque control procedures and because 
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plaque control3,8. In an attempt to overcome these 
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Because PVP-I is a potent antiseptic and its use 
in the treatment of non-molar teeth with chronic 
periodontitis has shown promising results13,26, the 
present study has been designed to evaluate the 
use of locally applied PVP-I as an adjunct to non-
surgical therapy of interproximal class II furcation 
involvements.
However, in the present study, both groups 
presented similar means of PPD reduction and 
RAL and HRAL gain. No benefit on the use 
of antimicrobials in the treatment of class II 
mandibular furcation was also shown by Tonetti, 
et al.30 (1998).
In the present study, difference between groups 
was observed, at 6 months, in BAPNA values. 
Test group had lower levels of trypsin-like activity 
than the control group. Trypsin-like enzyme is 
produced by important periodontal pathogens such 
as Tannerella forsythia, Treponema denticola and 
Porphyromonas gingivalis and is associated with 
signs of periodontitis32. These microorganisms 
are increased in diseased sites, when compared 
to stable ones22. Strong evidence also supports 
the report of T. forsythia and P. gingivalis as risk 
indicators of periodontal disease33. This information 
raises the doubt if the lower values of BAPNA in the 
group where PVP-I was used will be followed by a 
lower average of disease recurrence.
The BAPNA results could be related to the higher 
percentage of sites presenting, at 6 months, PPD 
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This is an important result since according to Claffey 
and Egelberg6 (1995) patients demonstrating a high 
proportion of deep pockets following initial cause 
related therapy are more likely to experience further 
clinical attachment loss.
However, no difference was observed in the 
number of sites referred for re-treatment. This 
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#W
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CONTROL GROUP TEST GROUP
Baseline 37.45±26.18 45.97±22.22
1 month 21.58±24.87* 17.95±8.76*
3 months 17.59±15.71* 23.38±20.88*
6 months 39.98±38.14† 18.10±14.61*†
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parameter is an important indicator of the clinical 
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percentage of sites that returned to health and to 
the percentage of sites still requiring therapy14. 
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BOP is an important outcome measurement as the 
absence of bleeding on probing in recall patients has 
been associated with clinical stability over time16. 
BOP and PPD are the accepted indicators of the 
response to root debridement31. At 3 and 6 months 
after therapy the percentage of sites re-treated 
was 30.00% and 33.33% in the control group and 
26.31% and 42.10% in the test group, respectively. 
This means that at 6 months only 66.67% of control 
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	'#
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without BOP.
+
	@#

#

to treat not only with non-surgical therapy, but also 
with guided tissue regeneration. In a regeneration 
furcation study, the largest clinical improvement 
was found in class II furcation defects of mandibular 
molars, followed by buccal class II furcations of 
maxillary molars and, interproximal furcation 
lesions exhibiting the least or no improvement23.
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furcation involvement could not be overcome by the 
use of PVP-I as adjunct to non-surgical therapy even 
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access the furcation area. These tips were used since 
it is known that areas inaccessible to instruments 
are also inaccessible to the cooling liquid. Also it 
has been shown that furcation entrances have in 
general smaller dimensions than the width of a 
Gracey curette, but they are larger than the average 
dimension of a new standard ultrasonic tip5. This 
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instruments are more effective than hand scaling in 
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of spirochetes and other motile organisms in class 
II and III furcation involvements17.
The decision to employ a 10% solution of 
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(1990). They determined that only the in vivo 
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total colony forming units of subgingival pockets. 
Other in vitro studies showed bactericidal effect 
with lower concentration of PVP-I27. However, in 
vitro

;
in vivo results because 
intraoral findings can be affected by salivary 
dilution, protein deactivation, and the inability of 
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(2003) also used 10% PVP-I subgingival irrigation in 
periodontitis lesions showing radiographic evidence 
of subgingival calculus.
  
CONCLUSION
It may be concluded, based on the design of the 
study, that the use of PVP-I, as the cooling liquid of 
an ultrasonic device in the non-surgical treatment 
of interproximal class II furcation involvements 
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